TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
IMA

ImageneBio, Inc.

Healthcare · Biotechnology

4.90$ -2.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement IMA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
3,938.0% 181.3% 487.8% 152.0% 411.8% 11.1% 43.6% 129.1%
-3,838.0% -81.3% -387.8% -52.0% -311.8% 88.9% 56.4% -29.1%
3,895.4% 181.3% 487.8% 152.0% 411.8% 651.2% 917.4% 3,565.6%
292.7% 53.1% 96.4% 58.1% 142.2% 272.1% 239.7% 2,590.8%
4,188.1% 53.1% 96.4% 58.1% 142.2% 912.2% 1,113.5% 6,027.3%
-4,130.7% -134.5% -484.2% -110.2% -454.0% -823.3% -1,057.1% -6,056.4%
-4,127.8% -122.3% -481.4% -110.1% -440.3% -745.9% -1,044.4% -5,712.4%
0.5% 1.0% -13.7% -1.8% 0.4% -43.8%
-4,127.8% -122.3% -481.4% -110.1% -440.3% -744.2% -1,044.8% -5,668.6%
-4,085.2% -132.7% -481.0% -108.3% -435.5% -734.8% -1,000.8% -5,583.3%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?